MEBENDAZOLE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for mebendazole and what is the scope of freedom to operate?
Mebendazole
is the generic ingredient in two branded drugs marketed by Impax Labs Inc and Janssen Pharms, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for mebendazole. Two suppliers are listed for this compound.
Summary for MEBENDAZOLE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 3 |
Drug Master File Entries: | 9 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 142 |
Clinical Trials: | 29 |
Patent Applications: | 5,894 |
What excipients (inactive ingredients) are in MEBENDAZOLE? | MEBENDAZOLE excipients list |
DailyMed Link: | MEBENDAZOLE at DailyMed |
Recent Clinical Trials for MEBENDAZOLE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Health Clinics Limited | Phase 3 |
Leiden University Medical Center | Phase 2/Phase 3 |
European and Developing Countries Clinical Trials Partnership (EDCTP) | Phase 2/Phase 3 |
Pharmacology for MEBENDAZOLE
Drug Class | Anthelmintic |
Medical Subject Heading (MeSH) Categories for MEBENDAZOLE
Anatomical Therapeutic Chemical (ATC) Classes for MEBENDAZOLE
US Patents and Regulatory Information for MEBENDAZOLE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | VERMOX | mebendazole | TABLET, CHEWABLE;ORAL | 017481-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharms | VERMOX | mebendazole | TABLET, CHEWABLE;ORAL | 208398-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Impax Labs Inc | EMVERM | mebendazole | TABLET, CHEWABLE;ORAL | 073580-001 | Jan 4, 1995 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MEBENDAZOLE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | VERMOX | mebendazole | TABLET, CHEWABLE;ORAL | 017481-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.